262
Participants
Start Date
September 13, 2012
Primary Completion Date
December 7, 2020
Study Completion Date
December 7, 2020
National Institutes of Health Clinical Center, Bethesda
Dana Farber Cancer Institute, Boston
Alberta's Children's Hospital Hematology/Oncology/Transplant Program, Alberta
National Cancer Institute (NCI)
NIH